Details of the Drug

General Information of Drug (ID: DML9DJP)

Drug Name

2-Phenyl-3H-imidazo[4,5-c]quinoline

Synonyms

2-Phenyl-3H-imidazo[4,5-c]quinoline; 3H-Imidazo[4,5-c]quinoline,2-phenyl-; CHEMBL95085; SCHEMBL1423662

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

245.28

Logarithm of the Partition Coefficient (xlogp)

3.4

Rotatable Bond Count (rotbonds)

1

Hydrogen Bond Donor Count (hbonddonor)

1

Hydrogen Bond Acceptor Count (hbondacc)

2

Chemical Identifiers

Formula: C16H11N3
IUPAC Name: 2-phenyl-3H-imidazo[4,5-c]quinoline
Canonical SMILES: C1=CC=C(C=C1)C2=NC3=C(N2)C=NC4=CC=CC=C43
InChI: InChI=1S/C16H11N3/c1-2-6-11(7-3-1)16-18-14-10-17-13-9-5-4-8-12(13)15(14)19-16/h1-10H,(H,18,19)
InChIKey: ZGICTZVKFFYIEA-UHFFFAOYSA-N

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
GABA(A) receptor alpha-1 (GABRA1)	TT1MPAY	GBRA1_HUMAN	Inhibitor	[1]
Gamma-aminobutyric acid receptor (GAR)	TTNJYV2	NOUNIPROTAC	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Synthesis and structure--activity relationships of fused imidazopyridines: a new series of benzodiazepine receptor ligands. J Med Chem. 1996 Jul 5;39(14):2844-51.